Literature DB >> 16938447

Patient's perception of exacerbations of COPD--the PERCEIVE study.

Marc Miravitlles1, Antonio Anzueto, Delfino Legnani, Leonhard Forstmeier, Matthias Fargel.   

Abstract

The evaluation of therapies requires the development of patient-reported outcomes (PROs) that help clinicians to understanding the symptoms, perceptions and feelings of patients with exacerbations of chronic obstructive pulmonary disease (COPD). With the aim of obtaining information on the perceptions of patients with COPD, their exacerbations and expectations of treatment, a random telephone contact survey in six countries was performed. From 83,592 households screened, 1100 subjects with symptoms compatible with COPD were identified. The most frequent symptom was shortness of breath (78%). The most frequent complaint was that due to their COPD: "they could not complete the activities they like to do" (54%); 17% (187) of individuals were afraid that their COPD would cripple, or eventually kill them. Exacerbations generated a mean of 5.1 medical visits/year (SD=4.6) with the mean duration of exacerbation symptoms being 10.5 days. Increased coughing was the exacerbation symptom having the strongest impact on well-being (42%). Fifty-five percent of patients declared that quicker symptom relief was the most desired requirement for treatment. New data are provided on the impact of COPD and its exacerbations on the daily life of patients. These data will help to develop PROs designed to evaluate the effectiveness of different therapies for exacerbated COPD.

Entities:  

Mesh:

Year:  2006        PMID: 16938447     DOI: 10.1016/j.rmed.2006.07.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  37 in total

1.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 2.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Authors:  Luis Javier Nannini; Toby J Lasserson; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Giving Voice to People - Experiences During Mild to Moderate Acute Exacerbations of COPD.

Authors:  Ana Machado; Sara Almeida; Chris Burtin; Alda Marques
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

4.  Stepped treatment algorithm using budesonide-formoterol for chronic respiratory diseases: A single arm interventional study.

Authors:  Wan-Chun Huang; Greg J Fox; Ngoc Yen Pham; Thu Anh Nguyen; Van Giap Vu; Viet Nhung Nguyen; Stephen Jan; Joel Negin; Quy Chau Ngo; Guy B Marks
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 5.  The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Authors:  Jill A Ohar; James F Donohue; Selwyn Spangenthal
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

6.  How do COPD patients respond to exacerbations?

Authors:  Jaap C A Trappenburg; David Schaap; Evelyn M Monninkhof; Jean Bourbeau; Gerdien H de Weert-van Oene; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2011-08-19       Impact factor: 3.317

Review 7.  Optimising treatment for COPD--new strategies for combination therapy.

Authors:  T Welte
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

8.  Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences.

Authors:  Shaonan Liu; Jiaqi Lai; Lei Wu; Xinfeng Guo
Journal:  Patient Prefer Adherence       Date:  2021-07-08       Impact factor: 2.711

9.  Patient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study.

Authors:  Yeon Jae Kim; Byung Ki Lee; Chi Young Jung; Young June Jeon; Dae Sung Hyun; Kyung Chan Kim; Sung Ken Yu; Hye Sook Choi; Won Hyuk Shin; Kwan Ho Lee
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

Review 10.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.